MATSUMOTO SHUNICHIRO
No ORCID on file
· 108 papers in corpus
· active 2005-2010
Frequent coauthors
- OHNUKI KEI 108
- KINOYAMA ISAO 108
- HIRANO MASAAKI 108
- KUSAYAMA TOSHIYUKI 108
- KAWAMINAMI EIJI 108
- OBITSU KAZUYOSHI 90
- HISAMICHI HIROYUKI 18
- YAMAMOTO HIROFUMI 18
- KOIKE TAKANORI 18
- OSODA KAZUHIKO 18
2010
Disclosed are 1,3-dihydro-2H-benzimidazol-2-ylidene derivatives as represented by the general formula (I) which are gonadotrophin releasing hormone (GnRH) receptor antagonists wherein A is optionally substituted aryl or optionally substitut…
2010
Disclosed are 1,3-dihydro-2H-benzimidazol-2-ylidene derivatives as represented by the general formula (I) which are gonadotrophin releasing hormone (GnRH) receptor antagonists wherein A is optionally substituted aryl or optionally substitut…
2010
Disclosed are 1,3-dihydro-2H-benzimidazol-2-ylidene derivatives as represented by the general formula (I) which are gonadotrophin releasing hormone (GnRH) receptor antagonists wherein A is optionally substituted aryl or optionally substitut…
2010
Disclosed are 1,3-dihydro-2H-benzimidazol-2-ylidene derivatives as represented by the general formula (I) which are gonadotrophin releasing hormone (GnRH) receptor antagonists wherein A is optionally substituted aryl or optionally substitut…
2010
Disclosed are 1,3-dihydro-2H-benzimidazol-2-ylidene derivatives as represented by the general formula (I) which are gonadotrophin releasing hormone (GnRH) receptor antagonists wherein A is optionally substituted aryl or optionally substitut…
2010
Disclosed are 1,3-dihydro-2H-benzimidazol-2-ylidene derivatives as represented by the general formula (I) which are gonadotrophin releasing hormone (GnRH) receptor antagonists wherein A is optionally substituted aryl or optionally substitut…
2010
Disclosed are 1,3-dihydro-2H-benzimidazol-2-ylidene derivatives as represented by the general formula (I) which are gonadotrophin releasing hormone (GnRH) receptor antagonists wherein A is optionally substituted aryl or optionally substitut…
2010
Disclosed are 1,3-dihydro-2H-benzimidazol-2-ylidene derivatives as represented by the general formula (I) which are gonadotrophin releasing hormone (GnRH) receptor antagonists wherein A is optionally substituted aryl or optionally substitut…
2010
Disclosed are 1,3-dihydro-2H-benzimidazol-2-ylidene derivatives as represented by the general formula (I) which are gonadotrophin releasing hormone (GnRH) receptor antagonists wherein A is optionally substituted aryl or optionally substitut…
2010
Disclosed are 1,3-dihydro-2H-benzimidazol-2-ylidene derivatives as represented by the general formula (I) which are gonadotrophin releasing hormone (GnRH) receptor antagonists wherein A is optionally substituted aryl or optionally substitut…
2010
Disclosed are 1,3-dihydro-2H-benzimidazol-2-ylidene derivatives as represented by the general formula (I) which are gonadotrophin releasing hormone (GnRH) receptor antagonists wherein A is optionally substituted aryl or optionally substitut…
2010
Disclosed are 1,3-dihydro-2H-benzimidazol-2-ylidene derivatives as represented by the general formula (I) which are gonadotrophin releasing hormone (GnRH) receptor antagonists wherein A is optionally substituted aryl or optionally substitut…
2010
Disclosed are 1,3-dihydro-2H-benzimidazol-2-ylidene derivatives as represented by the general formula (I) which are gonadotrophin releasing hormone (GnRH) receptor antagonists wherein A is optionally substituted aryl or optionally substitut…
2010
Disclosed are 1,3-dihydro-2H-benzimidazol-2-ylidene derivatives as represented by the general formula (I) which are gonadotrophin releasing hormone (GnRH) receptor antagonists wherein A is optionally substituted aryl or optionally substitut…
2010
Disclosed are 1,3-dihydro-2H-benzimidazol-2-ylidene derivatives as represented by the general formula (I) which are gonadotrophin releasing hormone (GnRH) receptor antagonists wherein A is optionally substituted aryl or optionally substitut…
2010
Disclosed are 1,3-dihydro-2H-benzimidazol-2-ylidene derivatives as represented by the general formula (I) which are gonadotrophin releasing hormone (GnRH) receptor antagonists wherein A is optionally substituted aryl or optionally substitut…
2010
Disclosed are 1,3-dihydro-2H-benzimidazol-2-ylidene derivatives as represented by the general formula (I) which are gonadotrophin releasing hormone (GnRH) receptor antagonists wherein A is optionally substituted aryl or optionally substitut…
2010
Disclosed are 1,3-dihydro-2H-benzimidazol-2-ylidene derivatives as represented by the general formula (I) which are gonadotrophin releasing hormone (GnRH) receptor antagonists wherein A is optionally substituted aryl or optionally substitut…
2010
Compounds useful as GnRH receptor antagonists are provided. The present inventors have further examined propane-1,3-dione derivatives and confirmed as a result that a propane-1,3-dione having 2-(1,3-dihydro-2H-benzimidazol-2-ylidene), or a …
2010
Compounds useful as GnRH receptor antagonists are provided. The present inventors have further examined propane-1,3-dione derivatives and confirmed as a result that a propane-1,3-dione having 2-(1,3-dihydro-2H-benzimidazol-2-ylidene), or a …
2010
Compounds useful as GnRH receptor antagonists are provided. The present inventors have further examined propane-1,3-dione derivatives and confirmed as a result that a propane-1,3-dione having 2-(1,3-dihydro-2H-benzimidazol-2-ylidene), or a …
2010
Compounds useful as GnRH receptor antagonists are provided. The present inventors have further examined propane-1,3-dione derivatives and confirmed as a result that a propane-1,3-dione having 2-(1,3-dihydro-2H-benzimidazol-2-ylidene), or a …
2010
Compounds useful as GnRH receptor antagonists are provided. The present inventors have further examined propane-1,3-dione derivatives and confirmed as a result that a propane-1,3-dione having 2-(1,3-dihydro-2H-benzimidazol-2-ylidene), or a …
2010
Compounds useful as GnRH receptor antagonists are provided. The present inventors have further examined propane-1,3-dione derivatives and confirmed as a result that a propane-1,3-dione having 2-(1,3-dihydro-2H-benzimidazol-2-ylidene), or a …
2010
Compounds useful as GnRH receptor antagonists are provided. The present inventors have further examined propane-1,3-dione derivatives and confirmed as a result that a propane-1,3-dione having 2-(1,3-dihydro-2H-benzimidazol-2-ylidene), or a …